AVACC 10
LIVE

Serial Number

79346219

Owner

Intravacc B.V.

Attorney

Jeffrey H. Greger

Filing Date

May 17, 2022

Add to watchlist:

No watchlists yet
View on USPTO

AVACC 10 Trademark

Serial Number: 79346219 • Registration: 7226960

AVACC 10 is a trademark filed by Intravacc B.V. on May 17, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Intravacc B.V. (4 trademarks)

Antonie van Leeuwenhoeklaan 9

Entity Type: 78

Trademark Details

Filing Date

May 17, 2022

Registration Date

November 28, 2023

Published for Opposition

September 12, 2023

Goods & Services

Pharmaceutical products and preparations for prevention, treatment and immune therapy and combinations of prevention, treatment and immune therapy of infectious diseases and allergic diseases, as well as pharmaceutical products and preparations against cancer; vaccines; and medicines for human use for prevention, treatment and immune therapy and combinations of prevention, treatment and immune therapy of infectious diseases, allergic diseases and cancer; bacterial and viral vaccines, synthetic, recombinant, peptide, protein, RNA-, DNA- and therapeutic vaccines; all the aforementioned products not for the ocular, periocular and vision field; all the aforementioned products not in relation to pharmaceutical medicines for cancer therapies consisting of and/or comprising antibodies; all the aforementioned products not in relation to pharmaceutical medicines for cancer therapies consisting of and/or comprising antibody drug conjugates

Apparatus and containers for the administration of vaccines and medicines, namely cups for dispensing medicine, injection needles for the administration of vaccines and medicines, injection instruments without needles for the administration of vaccines and medicines, nose sprayers for medical purposes and spray syringes for medical purposes; all the aforementioned products not for the ocular, periocular and vision field; all the aforementioned products not in relation to pharmaceutical medicines for cancer therapies consisting of and/or comprising antibodies; all the aforementioned products not in relation to pharmaceutical medicines for cancer therapies consisting of and/or comprising antibody drug conjugates

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 21, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 21, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 21, 2025 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 26, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 29, 2024 FICS
FINAL DISPOSITION PROCESSED
Feb 29, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 28, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 28, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 28, 2023 R.PR
NOTIFICATION PROCESSED BY IB
Sep 12, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 12, 2023 NPUB
PUBLISHED FOR OPPOSITION
Sep 12, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 23, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 23, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 23, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 4, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 26, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 26, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 26, 2023 TROA
REFUSAL PROCESSED BY IB
May 17, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 26, 2023 RFCS
REFUSAL PROCESSED BY MPU
Apr 26, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 8, 2023 RFCR
NON-FINAL ACTION WRITTEN
Mar 7, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 7, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 2, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 29, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 28, 2022 REPR